Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Hunninghake

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Cleveland Clinic Journal of Medicine|November 1, 1993
Which patients need aggressive lipid-altering therapy?D B Hunninghake
Postgraduate Medicine|April 1, 1972
Variable drug responses in manD B Hunninghake
The American Journal of Medicine|May 23, 1983
Pharmacologic therapy for the hyperlipidemic patientD B Hunninghake
American Heart Journal|March 1, 1991
The effects of cardioselective vasodilating beta-blockers on lipidsD B Hunninghake
Endocrinology and Metabolism Clinics of North America|June 1, 1990
Drug treatment of dyslipoproteinemiaD B Hunninghake
Contemporary Internal Medicine|January 8, 1995
Practical management for hyperlipidemiaJ G Robinson, D B Hunninghake
The Journal of Clinical Endocrinology and Metabolism|January 1, 1975
Pharmacokinetics of propylthiouracil in man after a single oral doseD S Sitar, D B Hunninghake
The American Journal of Medicine|February 14, 1986
Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertensionR H Grimm, D B Hunninghake
Contemporary Internal Medicine|November 4, 1994
Highlights of the new recommendations for hypercholesterolemiaJ G Robinson, D B Hunninghake
Journal of Clinical Pharmacology|January 1, 1983
A multiclinic double-blind comparison of timolol and hydrochlorothiazide alone and in combination in th e treatment of essential hypertensionA S Leon, D B Hunninghake
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Cleveland Clinic Journal of Medicine|November 1, 1993
Which patients need aggressive lipid-altering therapy?D B Hunninghake
Postgraduate Medicine|April 1, 1972
Variable drug responses in manD B Hunninghake
The American Journal of Medicine|May 23, 1983
Pharmacologic therapy for the hyperlipidemic patientD B Hunninghake
American Heart Journal|March 1, 1991
The effects of cardioselective vasodilating beta-blockers on lipidsD B Hunninghake
Endocrinology and Metabolism Clinics of North America|June 1, 1990
Drug treatment of dyslipoproteinemiaD B Hunninghake
Contemporary Internal Medicine|January 8, 1995
Practical management for hyperlipidemiaJ G Robinson, D B Hunninghake
The Journal of Clinical Endocrinology and Metabolism|January 1, 1975
Pharmacokinetics of propylthiouracil in man after a single oral doseD S Sitar, D B Hunninghake
The American Journal of Medicine|February 14, 1986
Lipids and hypertension. Implications of new guidelines for cholesterol management in the treatment of hypertensionR H Grimm, D B Hunninghake
Contemporary Internal Medicine|November 4, 1994
Highlights of the new recommendations for hypercholesterolemiaJ G Robinson, D B Hunninghake
Journal of Clinical Pharmacology|January 1, 1983
A multiclinic double-blind comparison of timolol and hydrochlorothiazide alone and in combination in th e treatment of essential hypertensionA S Leon, D B Hunninghake
Pageof 14